Physical health-related quality of life

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Membership in the Tired-Rundown class at hospital discharge predicted poorer physical health-related quality of life at 3 and 12 months post-ICD implant compared to the Mostly Asymptomatic class.

Effect: decline; p < 0.001

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4